nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP2C8—Levothyroxine—hypothyroidism	0.135	0.227	CbGbCtD
Morphine—CYP2C8—Liotrix—hypothyroidism	0.132	0.222	CbGbCtD
Morphine—ABCB1—Levothyroxine—hypothyroidism	0.0916	0.154	CbGbCtD
Morphine—ABCB1—Liothyronine—hypothyroidism	0.0916	0.154	CbGbCtD
Morphine—ABCB1—Liotrix—hypothyroidism	0.0894	0.15	CbGbCtD
Morphine—CYP3A4—Levothyroxine—hypothyroidism	0.0549	0.0923	CbGbCtD
Morphine—UGT1A8—tongue—hypothyroidism	0.0166	0.161	CbGeAlD
Morphine—UGT1A1—urine—hypothyroidism	0.0107	0.104	CbGeAlD
Morphine—Faecalith—Liotrix—hypothyroidism	0.00869	0.0315	CcSEcCtD
Morphine—Faecaloma—Liotrix—hypothyroidism	0.00869	0.0315	CcSEcCtD
Morphine—Muscle twitching—Liothyronine—hypothyroidism	0.007	0.0254	CcSEcCtD
Morphine—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00609	0.0221	CcSEcCtD
Morphine—Menstruation irregular—Levothyroxine—hypothyroidism	0.00609	0.0221	CcSEcCtD
Morphine—UGT2B4—heart—hypothyroidism	0.00585	0.0567	CbGeAlD
Morphine—OPRM1—nerve—hypothyroidism	0.0058	0.0563	CbGeAlD
Morphine—Phlebitis—Liothyronine—hypothyroidism	0.00579	0.021	CcSEcCtD
Morphine—UGT2B4—cardiovascular system—hypothyroidism	0.00552	0.0535	CbGeAlD
Morphine—OPRL1—adrenal gland—hypothyroidism	0.00458	0.0444	CbGeAlD
Morphine—OPRL1—blood—hypothyroidism	0.00458	0.0444	CbGeAlD
Morphine—Menstruation irregular—Liotrix—hypothyroidism	0.00448	0.0163	CcSEcCtD
Morphine—OPRL1—testis—hypothyroidism	0.00378	0.0367	CbGeAlD
Morphine—UGT1A8—liver—hypothyroidism	0.00367	0.0356	CbGeAlD
Morphine—Intestinal obstruction—Liotrix—hypothyroidism	0.00364	0.0132	CcSEcCtD
Morphine—Cyanosis—Liotrix—hypothyroidism	0.00351	0.0127	CcSEcCtD
Morphine—CYP3A4—urine—hypothyroidism	0.00343	0.0332	CbGeAlD
Morphine—UGT2B4—liver—hypothyroidism	0.00341	0.0331	CbGeAlD
Morphine—CYP2D6—urine—hypothyroidism	0.00337	0.0327	CbGeAlD
Morphine—Wheezing—Levothyroxine—hypothyroidism	0.00328	0.0119	CcSEcCtD
Morphine—Wheezing—Dextrothyroxine—hypothyroidism	0.00328	0.0119	CcSEcCtD
Morphine—UGT1A3—liver—hypothyroidism	0.00327	0.0317	CbGeAlD
Morphine—Coma—Dextrothyroxine—hypothyroidism	0.00308	0.0112	CcSEcCtD
Morphine—Coma—Levothyroxine—hypothyroidism	0.00308	0.0112	CcSEcCtD
Morphine—UGT2B15—liver—hypothyroidism	0.00308	0.0298	CbGeAlD
Morphine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00294	0.0107	CcSEcCtD
Morphine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00294	0.0107	CcSEcCtD
Morphine—Tenderness—Liotrix—hypothyroidism	0.00284	0.0103	CcSEcCtD
Morphine—Disorientation—Dextrothyroxine—hypothyroidism	0.00274	0.00994	CcSEcCtD
Morphine—Disorientation—Levothyroxine—hypothyroidism	0.00274	0.00994	CcSEcCtD
Morphine—Oliguria—Liotrix—hypothyroidism	0.00269	0.00978	CcSEcCtD
Morphine—Ulcer—Liotrix—hypothyroidism	0.00262	0.00953	CcSEcCtD
Morphine—Hypertension—Liothyronine—hypothyroidism	0.00259	0.00942	CcSEcCtD
Morphine—Muscle twitching—Liotrix—hypothyroidism	0.00253	0.00918	CcSEcCtD
Morphine—Affect lability—Dextrothyroxine—hypothyroidism	0.00241	0.00876	CcSEcCtD
Morphine—Affect lability—Levothyroxine—hypothyroidism	0.00241	0.00876	CcSEcCtD
Morphine—Wheezing—Liotrix—hypothyroidism	0.00241	0.00875	CcSEcCtD
Morphine—Tachycardia—Liothyronine—hypothyroidism	0.00239	0.00869	CcSEcCtD
Morphine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00233	0.00846	CcSEcCtD
Morphine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00233	0.00846	CcSEcCtD
Morphine—Mood swings—Dextrothyroxine—hypothyroidism	0.00232	0.00843	CcSEcCtD
Morphine—Mood swings—Levothyroxine—hypothyroidism	0.00232	0.00843	CcSEcCtD
Morphine—Hypotension—Liothyronine—hypothyroidism	0.00229	0.00832	CcSEcCtD
Morphine—Dehydration—Dextrothyroxine—hypothyroidism	0.00228	0.00827	CcSEcCtD
Morphine—Dehydration—Levothyroxine—hypothyroidism	0.00228	0.00827	CcSEcCtD
Morphine—Coma—Liotrix—hypothyroidism	0.00227	0.00824	CcSEcCtD
Morphine—Lightheadedness—Liotrix—hypothyroidism	0.00222	0.00807	CcSEcCtD
Morphine—Hyperkinesia—Liotrix—hypothyroidism	0.00216	0.00786	CcSEcCtD
Morphine—Sepsis—Liotrix—hypothyroidism	0.00215	0.00782	CcSEcCtD
Morphine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00212	0.00769	CcSEcCtD
Morphine—Dysphagia—Levothyroxine—hypothyroidism	0.00212	0.00769	CcSEcCtD
Morphine—Phlebitis—Liotrix—hypothyroidism	0.00209	0.0076	CcSEcCtD
Morphine—Sweating increased—Levothyroxine—hypothyroidism	0.00206	0.00749	CcSEcCtD
Morphine—Sweating increased—Dextrothyroxine—hypothyroidism	0.00206	0.00749	CcSEcCtD
Morphine—UGT1A1—blood—hypothyroidism	0.00204	0.0198	CbGeAlD
Morphine—Swelling—Liotrix—hypothyroidism	0.00204	0.00742	CcSEcCtD
Morphine—Disorientation—Liotrix—hypothyroidism	0.00201	0.00731	CcSEcCtD
Morphine—UGT2B7—testis—hypothyroidism	0.00199	0.0193	CbGeAlD
Morphine—Body temperature increased—Liothyronine—hypothyroidism	0.00194	0.00704	CcSEcCtD
Morphine—Weight decreased—Levothyroxine—hypothyroidism	0.00192	0.00696	CcSEcCtD
Morphine—Weight decreased—Dextrothyroxine—hypothyroidism	0.00192	0.00696	CcSEcCtD
Morphine—Renal impairment—Liotrix—hypothyroidism	0.00189	0.00688	CcSEcCtD
Morphine—UGT2B7—liver—hypothyroidism	0.00188	0.0182	CbGeAlD
Morphine—Sweating—Levothyroxine—hypothyroidism	0.00181	0.00657	CcSEcCtD
Morphine—Sweating—Dextrothyroxine—hypothyroidism	0.00181	0.00657	CcSEcCtD
Morphine—Affect lability—Liotrix—hypothyroidism	0.00177	0.00644	CcSEcCtD
Morphine—OPRK1—cerebellum—hypothyroidism	0.00173	0.0167	CbGeAlD
Morphine—Cardiac arrest—Liotrix—hypothyroidism	0.00171	0.00622	CcSEcCtD
Morphine—Mood swings—Liotrix—hypothyroidism	0.00171	0.0062	CcSEcCtD
Morphine—Dehydration—Liotrix—hypothyroidism	0.00168	0.00609	CcSEcCtD
Morphine—Hypokalaemia—Liotrix—hypothyroidism	0.00164	0.00596	CcSEcCtD
Morphine—OPRM1—blood—hypothyroidism	0.00161	0.0156	CbGeAlD
Morphine—UGT1A1—liver—hypothyroidism	0.0016	0.0155	CbGeAlD
Morphine—Flushing—Dextrothyroxine—hypothyroidism	0.00157	0.00571	CcSEcCtD
Morphine—Flushing—Levothyroxine—hypothyroidism	0.00157	0.00571	CcSEcCtD
Morphine—Abdominal distension—Liotrix—hypothyroidism	0.00157	0.00569	CcSEcCtD
Morphine—Dysphagia—Liotrix—hypothyroidism	0.00156	0.00566	CcSEcCtD
Morphine—Bronchospasm—Liotrix—hypothyroidism	0.00153	0.00556	CcSEcCtD
Morphine—Sweating increased—Liotrix—hypothyroidism	0.00152	0.00551	CcSEcCtD
Morphine—Tension—Dextrothyroxine—hypothyroidism	0.00145	0.00526	CcSEcCtD
Morphine—Tension—Levothyroxine—hypothyroidism	0.00145	0.00526	CcSEcCtD
Morphine—Nervousness—Dextrothyroxine—hypothyroidism	0.00143	0.0052	CcSEcCtD
Morphine—Nervousness—Levothyroxine—hypothyroidism	0.00143	0.0052	CcSEcCtD
Morphine—Weight decreased—Liotrix—hypothyroidism	0.00141	0.00512	CcSEcCtD
Morphine—Tremor—Levothyroxine—hypothyroidism	0.00138	0.00502	CcSEcCtD
Morphine—Tremor—Dextrothyroxine—hypothyroidism	0.00138	0.00502	CcSEcCtD
Morphine—Renal failure—Liotrix—hypothyroidism	0.00136	0.00496	CcSEcCtD
Morphine—Agitation—Levothyroxine—hypothyroidism	0.00136	0.00492	CcSEcCtD
Morphine—Agitation—Dextrothyroxine—hypothyroidism	0.00136	0.00492	CcSEcCtD
Morphine—Sweating—Liotrix—hypothyroidism	0.00133	0.00483	CcSEcCtD
Morphine—OPRM1—testis—hypothyroidism	0.00133	0.0129	CbGeAlD
Morphine—Palpitations—Dextrothyroxine—hypothyroidism	0.0013	0.00473	CcSEcCtD
Morphine—Palpitations—Levothyroxine—hypothyroidism	0.0013	0.00473	CcSEcCtD
Morphine—Convulsion—Levothyroxine—hypothyroidism	0.00128	0.00464	CcSEcCtD
Morphine—Convulsion—Dextrothyroxine—hypothyroidism	0.00128	0.00464	CcSEcCtD
Morphine—Arthralgia—Levothyroxine—hypothyroidism	0.00126	0.00456	CcSEcCtD
Morphine—Arthralgia—Dextrothyroxine—hypothyroidism	0.00126	0.00456	CcSEcCtD
Morphine—Anxiety—Dextrothyroxine—hypothyroidism	0.00125	0.00455	CcSEcCtD
Morphine—Anxiety—Levothyroxine—hypothyroidism	0.00125	0.00455	CcSEcCtD
Morphine—Hypoaesthesia—Liotrix—hypothyroidism	0.00124	0.0045	CcSEcCtD
Morphine—Confusional state—Dextrothyroxine—hypothyroidism	0.00121	0.00441	CcSEcCtD
Morphine—Confusional state—Levothyroxine—hypothyroidism	0.00121	0.00441	CcSEcCtD
Morphine—Shock—Levothyroxine—hypothyroidism	0.00118	0.0043	CcSEcCtD
Morphine—Shock—Dextrothyroxine—hypothyroidism	0.00118	0.0043	CcSEcCtD
Morphine—Tachycardia—Levothyroxine—hypothyroidism	0.00117	0.00427	CcSEcCtD
Morphine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00117	0.00427	CcSEcCtD
Morphine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00116	0.00423	CcSEcCtD
Morphine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00116	0.00423	CcSEcCtD
Morphine—Flushing—Liotrix—hypothyroidism	0.00116	0.0042	CcSEcCtD
Morphine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.0011	0.00398	CcSEcCtD
Morphine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.0011	0.00398	CcSEcCtD
Morphine—Insomnia—Levothyroxine—hypothyroidism	0.00109	0.00395	CcSEcCtD
Morphine—Insomnia—Dextrothyroxine—hypothyroidism	0.00109	0.00395	CcSEcCtD
Morphine—CYP2C8—pituitary gland—hypothyroidism	0.00108	0.0105	CbGeAlD
Morphine—Dyspnoea—Levothyroxine—hypothyroidism	0.00107	0.0039	CcSEcCtD
Morphine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00107	0.0039	CcSEcCtD
Morphine—Flatulence—Liotrix—hypothyroidism	0.00107	0.00388	CcSEcCtD
Morphine—Tension—Liotrix—hypothyroidism	0.00106	0.00387	CcSEcCtD
Morphine—Dysgeusia—Liotrix—hypothyroidism	0.00106	0.00386	CcSEcCtD
Morphine—Nervousness—Liotrix—hypothyroidism	0.00105	0.00383	CcSEcCtD
Morphine—Fatigue—Dextrothyroxine—hypothyroidism	0.00104	0.00377	CcSEcCtD
Morphine—Fatigue—Levothyroxine—hypothyroidism	0.00104	0.00377	CcSEcCtD
Morphine—Vision blurred—Liotrix—hypothyroidism	0.00102	0.00371	CcSEcCtD
Morphine—Tremor—Liotrix—hypothyroidism	0.00102	0.00369	CcSEcCtD
Morphine—Agitation—Liotrix—hypothyroidism	0.000997	0.00362	CcSEcCtD
Morphine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000992	0.0036	CcSEcCtD
Morphine—Feeling abnormal—Levothyroxine—hypothyroidism	0.000992	0.0036	CcSEcCtD
Morphine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000984	0.00358	CcSEcCtD
Morphine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000984	0.00358	CcSEcCtD
Morphine—Syncope—Liotrix—hypothyroidism	0.000973	0.00353	CcSEcCtD
Morphine—CYP2C8—blood—hypothyroidism	0.000967	0.00938	CbGeAlD
Morphine—Palpitations—Liotrix—hypothyroidism	0.000959	0.00348	CcSEcCtD
Morphine—Urticaria—Levothyroxine—hypothyroidism	0.000956	0.00347	CcSEcCtD
Morphine—Urticaria—Dextrothyroxine—hypothyroidism	0.000956	0.00347	CcSEcCtD
Morphine—Loss of consciousness—Liotrix—hypothyroidism	0.000954	0.00346	CcSEcCtD
Morphine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000952	0.00346	CcSEcCtD
Morphine—Abdominal pain—Levothyroxine—hypothyroidism	0.000952	0.00346	CcSEcCtD
Morphine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000952	0.00346	CcSEcCtD
Morphine—Body temperature increased—Levothyroxine—hypothyroidism	0.000952	0.00346	CcSEcCtD
Morphine—Convulsion—Liotrix—hypothyroidism	0.00094	0.00341	CcSEcCtD
Morphine—Hypertension—Liotrix—hypothyroidism	0.000937	0.0034	CcSEcCtD
Morphine—Arthralgia—Liotrix—hypothyroidism	0.000924	0.00335	CcSEcCtD
Morphine—Chest pain—Liotrix—hypothyroidism	0.000924	0.00335	CcSEcCtD
Morphine—Anxiety—Liotrix—hypothyroidism	0.000921	0.00334	CcSEcCtD
Morphine—Confusional state—Liotrix—hypothyroidism	0.000893	0.00324	CcSEcCtD
Morphine—Anaphylactic shock—Liotrix—hypothyroidism	0.000886	0.00322	CcSEcCtD
Morphine—Oedema—Liotrix—hypothyroidism	0.000886	0.00322	CcSEcCtD
Morphine—Infection—Liotrix—hypothyroidism	0.00088	0.0032	CcSEcCtD
Morphine—Shock—Liotrix—hypothyroidism	0.000871	0.00316	CcSEcCtD
Morphine—Tachycardia—Liotrix—hypothyroidism	0.000864	0.00314	CcSEcCtD
Morphine—Asthenia—Dextrothyroxine—hypothyroidism	0.000864	0.00314	CcSEcCtD
Morphine—Asthenia—Levothyroxine—hypothyroidism	0.000864	0.00314	CcSEcCtD
Morphine—Hyperhidrosis—Liotrix—hypothyroidism	0.000856	0.00311	CcSEcCtD
Morphine—Pruritus—Levothyroxine—hypothyroidism	0.000852	0.00309	CcSEcCtD
Morphine—Pruritus—Dextrothyroxine—hypothyroidism	0.000852	0.00309	CcSEcCtD
Morphine—Anorexia—Liotrix—hypothyroidism	0.000844	0.00307	CcSEcCtD
Morphine—Hypotension—Liotrix—hypothyroidism	0.000827	0.00301	CcSEcCtD
Morphine—Diarrhoea—Levothyroxine—hypothyroidism	0.000824	0.00299	CcSEcCtD
Morphine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000824	0.00299	CcSEcCtD
Morphine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000807	0.00293	CcSEcCtD
Morphine—Insomnia—Liotrix—hypothyroidism	0.000801	0.00291	CcSEcCtD
Morphine—CYP2C8—testis—hypothyroidism	0.0008	0.00776	CbGeAlD
Morphine—Paraesthesia—Liotrix—hypothyroidism	0.000795	0.00289	CcSEcCtD
Morphine—Dyspnoea—Liotrix—hypothyroidism	0.000789	0.00287	CcSEcCtD
Morphine—Decreased appetite—Liotrix—hypothyroidism	0.00077	0.0028	CcSEcCtD
Morphine—Vomiting—Levothyroxine—hypothyroidism	0.000765	0.00278	CcSEcCtD
Morphine—Vomiting—Dextrothyroxine—hypothyroidism	0.000765	0.00278	CcSEcCtD
Morphine—Fatigue—Liotrix—hypothyroidism	0.000763	0.00277	CcSEcCtD
Morphine—Rash—Dextrothyroxine—hypothyroidism	0.000759	0.00276	CcSEcCtD
Morphine—Rash—Levothyroxine—hypothyroidism	0.000759	0.00276	CcSEcCtD
Morphine—Dermatitis—Levothyroxine—hypothyroidism	0.000758	0.00275	CcSEcCtD
Morphine—Dermatitis—Dextrothyroxine—hypothyroidism	0.000758	0.00275	CcSEcCtD
Morphine—Constipation—Liotrix—hypothyroidism	0.000757	0.00275	CcSEcCtD
Morphine—CYP2C8—liver—hypothyroidism	0.000756	0.00733	CbGeAlD
Morphine—Headache—Dextrothyroxine—hypothyroidism	0.000754	0.00274	CcSEcCtD
Morphine—Headache—Levothyroxine—hypothyroidism	0.000754	0.00274	CcSEcCtD
Morphine—Feeling abnormal—Liotrix—hypothyroidism	0.00073	0.00265	CcSEcCtD
Morphine—Gastrointestinal pain—Liotrix—hypothyroidism	0.000724	0.00263	CcSEcCtD
Morphine—Nausea—Levothyroxine—hypothyroidism	0.000715	0.0026	CcSEcCtD
Morphine—Nausea—Dextrothyroxine—hypothyroidism	0.000715	0.0026	CcSEcCtD
Morphine—Urticaria—Liotrix—hypothyroidism	0.000703	0.00255	CcSEcCtD
Morphine—Body temperature increased—Liotrix—hypothyroidism	0.0007	0.00254	CcSEcCtD
Morphine—Abdominal pain—Liotrix—hypothyroidism	0.0007	0.00254	CcSEcCtD
Morphine—CYP3A4—blood—hypothyroidism	0.000655	0.00635	CbGeAlD
Morphine—Hypersensitivity—Liotrix—hypothyroidism	0.000652	0.00237	CcSEcCtD
Morphine—CYP2D6—blood—hypothyroidism	0.000644	0.00625	CbGeAlD
Morphine—ABCB1—adrenal cortex—hypothyroidism	0.000642	0.00623	CbGeAlD
Morphine—Asthenia—Liotrix—hypothyroidism	0.000635	0.00231	CcSEcCtD
Morphine—OPRL1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000634	0.0238	CbGpPWpGaD
Morphine—Pruritus—Liotrix—hypothyroidism	0.000627	0.00228	CcSEcCtD
Morphine—ABCB1—heart—hypothyroidism	0.000621	0.00603	CbGeAlD
Morphine—UGT1A3—NRF2 pathway—SLC5A7—hypothyroidism	0.000612	0.023	CbGpPWpGaD
Morphine—Diarrhoea—Liotrix—hypothyroidism	0.000606	0.0022	CcSEcCtD
Morphine—CYP2D6—female gonad—hypothyroidism	0.000601	0.00583	CbGeAlD
Morphine—ABCB1—cardiovascular system—hypothyroidism	0.000586	0.00569	CbGeAlD
Morphine—Dizziness—Liotrix—hypothyroidism	0.000586	0.00213	CcSEcCtD
Morphine—Vomiting—Liotrix—hypothyroidism	0.000563	0.00204	CcSEcCtD
Morphine—Rash—Liotrix—hypothyroidism	0.000558	0.00203	CcSEcCtD
Morphine—Dermatitis—Liotrix—hypothyroidism	0.000558	0.00203	CcSEcCtD
Morphine—Headache—Liotrix—hypothyroidism	0.000555	0.00201	CcSEcCtD
Morphine—CYP2D6—testis—hypothyroidism	0.000533	0.00517	CbGeAlD
Morphine—ABCB1—gonad—hypothyroidism	0.000532	0.00516	CbGeAlD
Morphine—Nausea—Liotrix—hypothyroidism	0.000526	0.00191	CcSEcCtD
Morphine—UGT2B7—NRF2 pathway—SLC5A7—hypothyroidism	0.00052	0.0196	CbGpPWpGaD
Morphine—ABCB1—pituitary gland—hypothyroidism	0.000519	0.00503	CbGeAlD
Morphine—OPRD1—Peptide GPCRs—TSHR—hypothyroidism	0.000513	0.0193	CbGpPWpGaD
Morphine—CYP3A4—liver—hypothyroidism	0.000512	0.00497	CbGeAlD
Morphine—CYP2D6—liver—hypothyroidism	0.000504	0.00489	CbGeAlD
Morphine—CYP2D6—cerebellum—hypothyroidism	0.000492	0.00478	CbGeAlD
Morphine—ABCB1—adrenal gland—hypothyroidism	0.000464	0.0045	CbGeAlD
Morphine—ABCB1—blood—hypothyroidism	0.000464	0.0045	CbGeAlD
Morphine—OPRK1—Peptide GPCRs—TSHR—hypothyroidism	0.00045	0.0169	CbGpPWpGaD
Morphine—ABCB1—thyroid gland—hypothyroidism	0.000447	0.00434	CbGeAlD
Morphine—ABCB1—female gonad—hypothyroidism	0.000432	0.00419	CbGeAlD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000425	0.016	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—SLC5A7—hypothyroidism	0.000423	0.0159	CbGpPWpGaD
Morphine—ABCB1—testis—hypothyroidism	0.000383	0.00372	CbGeAlD
Morphine—OPRM1—Peptide GPCRs—TSHR—hypothyroidism	0.00038	0.0143	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000379	0.0143	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000379	0.0143	CbGpPWpGaD
Morphine—ABCB1—liver—hypothyroidism	0.000363	0.00352	CbGeAlD
Morphine—ABCB1—cerebellum—hypothyroidism	0.000354	0.00344	CbGeAlD
Morphine—OPRM1—G-protein activation—POMC—hypothyroidism	0.000333	0.0125	CbGpPWpGaD
Morphine—OPRL1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000333	0.0125	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—TRH—hypothyroidism	0.000324	0.0122	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—AVP—hypothyroidism	0.000318	0.012	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00029	0.0109	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—TSHB—hypothyroidism	0.000289	0.0109	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—TSHR—hypothyroidism	0.000289	0.0109	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—IYD—hypothyroidism	0.000283	0.0106	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000271	0.0102	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—IYD—hypothyroidism	0.000247	0.00929	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—IYD—hypothyroidism	0.000247	0.00929	CbGpPWpGaD
Morphine—UGT1A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000244	0.00919	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ATP5O—hypothyroidism	0.00024	0.00904	CbGpPWpGaD
Morphine—UGT1A8—Biological oxidations—POMC—hypothyroidism	0.00024	0.00901	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000237	0.00892	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—TPO—hypothyroidism	0.000226	0.0085	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000223	0.0084	CbGpPWpGaD
Morphine—OPRL1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000221	0.00832	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ATP5O—hypothyroidism	0.00021	0.0079	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ATP5O—hypothyroidism	0.00021	0.0079	CbGpPWpGaD
Morphine—UGT2B4—Biological oxidations—POMC—hypothyroidism	0.000209	0.00788	CbGpPWpGaD
Morphine—UGT2B15—Biological oxidations—POMC—hypothyroidism	0.000209	0.00788	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—SLC5A5—hypothyroidism	0.000208	0.00782	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0002	0.00754	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—VAV3—hypothyroidism	0.000199	0.00747	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—TPO—hypothyroidism	0.000198	0.00743	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—TPO—hypothyroidism	0.000198	0.00743	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—POMC—hypothyroidism	0.000187	0.00702	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—TRH—hypothyroidism	0.000183	0.00688	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000181	0.00682	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—AVP—hypothyroidism	0.00017	0.0064	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—SLC5A5—hypothyroidism	0.000169	0.00635	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—TRH—hypothyroidism	0.000166	0.00625	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—TSHB—hypothyroidism	0.000163	0.00613	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—TSHR—hypothyroidism	0.000163	0.00613	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000162	0.00608	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000162	0.00608	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000159	0.00598	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000148	0.00558	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—TSHB—hypothyroidism	0.000148	0.00557	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—TSHR—hypothyroidism	0.000148	0.00557	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000142	0.00534	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000142	0.00533	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000142	0.00533	CbGpPWpGaD
Morphine—OPRM1—Opioid Signalling—POMC—hypothyroidism	0.000138	0.00521	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—TRH—hypothyroidism	0.000138	0.0052	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000134	0.00506	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—IYD—hypothyroidism	0.000132	0.00498	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000125	0.00469	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—TSHR—hypothyroidism	0.000123	0.00463	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—TSHB—hypothyroidism	0.000123	0.00463	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—TRH—hypothyroidism	0.000121	0.00456	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00012	0.00451	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00012	0.00451	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CLTC—hypothyroidism	0.000114	0.00427	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—POMC—hypothyroidism	0.000113	0.00425	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ATP5O—hypothyroidism	0.000113	0.00423	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—IYD—hypothyroidism	0.000113	0.00423	CbGpPWpGaD
Morphine—UGT1A3—Biological oxidations—POMC—hypothyroidism	0.000112	0.00422	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—TSHB—hypothyroidism	0.000108	0.00406	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—TSHR—hypothyroidism	0.000108	0.00406	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TPO—hypothyroidism	0.000106	0.00398	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000105	0.00396	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—TSHB—hypothyroidism	0.000105	0.00393	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—TRH—hypothyroidism	0.000102	0.00385	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—VAV3—hypothyroidism	9.97e-05	0.00375	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TRH—hypothyroidism	9.81e-05	0.00369	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AVP—hypothyroidism	9.61e-05	0.00361	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ATP5O—hypothyroidism	9.57e-05	0.0036	CbGpPWpGaD
Morphine—UGT2B7—Biological oxidations—POMC—hypothyroidism	9.54e-05	0.00359	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	9.53e-05	0.00359	CbGpPWpGaD
Morphine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.48e-05	0.00356	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—POMC—hypothyroidism	9.44e-05	0.00355	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3C2A—hypothyroidism	9.32e-05	0.00351	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—TSHB—hypothyroidism	9.14e-05	0.00344	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—TSHB—hypothyroidism	9.14e-05	0.00344	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—IYD—hypothyroidism	9.14e-05	0.00344	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—TSHB—hypothyroidism	9.13e-05	0.00343	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—TSHR—hypothyroidism	9.13e-05	0.00343	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—VAV3—hypothyroidism	9.06e-05	0.00341	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TPO—hypothyroidism	9e-05	0.00338	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TSHB—hypothyroidism	8.75e-05	0.00329	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TSHR—hypothyroidism	8.75e-05	0.00329	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AVP—hypothyroidism	8.73e-05	0.00328	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	8.36e-05	0.00314	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—POMC—hypothyroidism	8.28e-05	0.00311	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3C2A—hypothyroidism	8.15e-05	0.00307	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3C2A—hypothyroidism	8.15e-05	0.00307	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—POMC—hypothyroidism	7.97e-05	0.003	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—SLC5A5—hypothyroidism	7.83e-05	0.00295	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TRH—hypothyroidism	7.81e-05	0.00294	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SH2B3—hypothyroidism	7.8e-05	0.00293	CbGpPWpGaD
Morphine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.78e-05	0.00293	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ATP5O—hypothyroidism	7.77e-05	0.00292	CbGpPWpGaD
Morphine—UGT1A1—Biological oxidations—POMC—hypothyroidism	7.75e-05	0.00291	CbGpPWpGaD
Morphine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.68e-05	0.00289	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TPO—hypothyroidism	7.31e-05	0.00275	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—AVP—hypothyroidism	7.26e-05	0.00273	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TRH—hypothyroidism	7.09e-05	0.00267	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.06e-05	0.00266	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	7e-05	0.00263	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—POMC—hypothyroidism	6.99e-05	0.00263	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TSHB—hypothyroidism	6.96e-05	0.00262	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TSHR—hypothyroidism	6.96e-05	0.00262	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TRH—hypothyroidism	6.85e-05	0.00258	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—SLC5A5—hypothyroidism	6.84e-05	0.00257	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—SLC5A5—hypothyroidism	6.84e-05	0.00257	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—POMC—hypothyroidism	6.39e-05	0.0024	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—AVP—hypothyroidism	6.37e-05	0.00239	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.33e-05	0.00238	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TSHR—hypothyroidism	6.32e-05	0.00238	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TSHB—hypothyroidism	6.32e-05	0.00238	CbGpPWpGaD
Morphine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.31e-05	0.00237	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TRH—hypothyroidism	6.22e-05	0.00234	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.21e-05	0.00233	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TSHR—hypothyroidism	6.1e-05	0.0023	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TSHB—hypothyroidism	6.1e-05	0.0023	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	5.9e-05	0.00222	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—POMC—hypothyroidism	5.8e-05	0.00218	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	5.79e-05	0.00218	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PRL—hypothyroidism	5.78e-05	0.00218	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.55e-05	0.00209	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TSHB—hypothyroidism	5.54e-05	0.00208	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TSHR—hypothyroidism	5.54e-05	0.00208	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—AVP—hypothyroidism	5.38e-05	0.00202	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VAV3—hypothyroidism	5.35e-05	0.00201	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TRH—hypothyroidism	5.26e-05	0.00198	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	5.16e-05	0.00194	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	5.16e-05	0.00194	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AVP—hypothyroidism	5.16e-05	0.00194	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.14e-05	0.00193	CbGpPWpGaD
Morphine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.09e-05	0.00191	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TSHB—hypothyroidism	4.9e-05	0.00184	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CLTC—hypothyroidism	4.85e-05	0.00182	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—POMC—hypothyroidism	4.82e-05	0.00181	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—IYD—hypothyroidism	4.81e-05	0.00181	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.69e-05	0.00177	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	4.68e-05	0.00176	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	4.68e-05	0.00176	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3C2A—hypothyroidism	4.37e-05	0.00164	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—VAV3—hypothyroidism	4.26e-05	0.0016	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CLTC—hypothyroidism	4.25e-05	0.0016	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—POMC—hypothyroidism	4.23e-05	0.00159	CbGpPWpGaD
Morphine—ABCB1—Metabolism—IYD—hypothyroidism	4.19e-05	0.00158	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TRH—hypothyroidism	4.19e-05	0.00158	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TSHB—hypothyroidism	4.16e-05	0.00157	CbGpPWpGaD
Morphine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.12e-05	0.00155	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AVP—hypothyroidism	4.1e-05	0.00154	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—POMC—hypothyroidism	4.1e-05	0.00154	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ATP5O—hypothyroidism	4.09e-05	0.00154	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—POMC—hypothyroidism	4.08e-05	0.00153	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—IYD—hypothyroidism	3.95e-05	0.00149	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—VAV3—hypothyroidism	3.87e-05	0.00145	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TPO—hypothyroidism	3.85e-05	0.00145	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TSHB—hypothyroidism	3.73e-05	0.0014	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TSHR—hypothyroidism	3.73e-05	0.0014	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—VAV3—hypothyroidism	3.73e-05	0.0014	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AVP—hypothyroidism	3.73e-05	0.0014	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3C2A—hypothyroidism	3.71e-05	0.0014	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TRH—hypothyroidism	3.67e-05	0.00138	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SLC5A5—hypothyroidism	3.67e-05	0.00138	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AVP—hypothyroidism	3.6e-05	0.00135	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CLTC—hypothyroidism	3.59e-05	0.00135	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—POMC—hypothyroidism	3.58e-05	0.00135	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—POMC—hypothyroidism	3.58e-05	0.00135	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—POMC—hypothyroidism	3.57e-05	0.00134	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ATP5O—hypothyroidism	3.57e-05	0.00134	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.57e-05	0.00134	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—POMC—hypothyroidism	3.43e-05	0.00129	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—VAV3—hypothyroidism	3.39e-05	0.00128	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TSHB—hypothyroidism	3.38e-05	0.00127	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ATP5O—hypothyroidism	3.36e-05	0.00126	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TPO—hypothyroidism	3.35e-05	0.00126	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—POMC—hypothyroidism	3.35e-05	0.00126	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SH2B3—hypothyroidism	3.33e-05	0.00125	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IGF1—hypothyroidism	3.3e-05	0.00124	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TSHB—hypothyroidism	3.27e-05	0.00123	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TSHR—hypothyroidism	3.27e-05	0.00123	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AVP—hypothyroidism	3.27e-05	0.00123	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TPO—hypothyroidism	3.16e-05	0.00119	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	3.16e-05	0.00119	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.14e-05	0.00118	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SLC5A5—hypothyroidism	3.12e-05	0.00117	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TRH—hypothyroidism	3.1e-05	0.00117	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	3.04e-05	0.00114	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	3.02e-05	0.00113	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SH2B3—hypothyroidism	2.92e-05	0.0011	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	2.87e-05	0.00108	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSHB—hypothyroidism	2.77e-05	0.00104	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSHR—hypothyroidism	2.77e-05	0.00104	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AVP—hypothyroidism	2.76e-05	0.00104	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—POMC—hypothyroidism	2.73e-05	0.00103	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IYD—hypothyroidism	2.58e-05	0.000972	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SLC5A5—hypothyroidism	2.53e-05	0.000953	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.48e-05	0.000933	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—POMC—hypothyroidism	2.48e-05	0.000931	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PRL—hypothyroidism	2.47e-05	0.000929	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	2.47e-05	0.000928	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—POMC—hypothyroidism	2.39e-05	0.000899	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VAV3—hypothyroidism	2.28e-05	0.000859	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AVP—hypothyroidism	2.2e-05	0.000828	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.2e-05	0.000826	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.19e-05	0.000824	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—POMC—hypothyroidism	2.17e-05	0.000816	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PRL—hypothyroidism	2.16e-05	0.000814	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TPO—hypothyroidism	2.07e-05	0.000777	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	2.02e-05	0.00076	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VAV3—hypothyroidism	2e-05	0.000753	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.95e-05	0.000735	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AVP—hypothyroidism	1.93e-05	0.000726	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—POMC—hypothyroidism	1.92e-05	0.000721	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—POMC—hypothyroidism	1.83e-05	0.00069	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PRL—hypothyroidism	1.83e-05	0.000688	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TSHB—hypothyroidism	1.78e-05	0.00067	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VAV3—hypothyroidism	1.69e-05	0.000637	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—POMC—hypothyroidism	1.63e-05	0.000613	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AVP—hypothyroidism	1.63e-05	0.000613	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.59e-05	0.000597	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.57e-05	0.000589	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TSHB—hypothyroidism	1.55e-05	0.000584	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TSHB—hypothyroidism	1.46e-05	0.00055	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—POMC—hypothyroidism	1.46e-05	0.00055	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—hypothyroidism	1.41e-05	0.000529	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.38e-05	0.00052	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.33e-05	0.000502	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—POMC—hypothyroidism	1.33e-05	0.000498	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.3e-05	0.00049	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—POMC—hypothyroidism	1.28e-05	0.000482	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—hypothyroidism	1.23e-05	0.000464	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.16e-05	0.000437	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.1e-05	0.000412	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—POMC—hypothyroidism	1.08e-05	0.000408	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—hypothyroidism	1.04e-05	0.000392	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TSHB—hypothyroidism	9.56e-06	0.00036	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.52e-06	0.000321	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.16e-06	0.000269	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—POMC—hypothyroidism	6.98e-06	0.000262	CbGpPWpGaD
Morphine—ABCB1—Metabolism—POMC—hypothyroidism	6.08e-06	0.000229	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—POMC—hypothyroidism	5.73e-06	0.000215	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—POMC—hypothyroidism	3.75e-06	0.000141	CbGpPWpGaD
